EPM
EW icon

Equitec Proprietary Markets’s Edwards Lifesciences EW Stock Holding History

Equitec Proprietary Markets’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,796
Closed -$123K – 285
2014
Q4 		$123K Buy
+5,796
New +$116K 0.01% 415

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Equitec Proprietary Markets's EW Position: Q1 2015 in Review

Equitec Proprietary Markets sold out of Edwards Lifesciences (EW) in Q1 2015, closing a stake of 5,796 shares — an estimated $123K sold.

Equitec Proprietary Markets first reported a position in EW in Q4 2014 and held it in 1 quarter. The position peaked at $123K in Q4 2014. 575 funds tracked by Wall St. Rank hold EW as of Q1 2015.

  • Equitec Proprietary Markets reported no remaining Edwards Lifesciences position as of Q1 2015 after selling out during the quarter.
  • Equitec Proprietary Markets sold 5,796 Edwards Lifesciences shares in Q1 2015, an estimated $123K.
  • Equitec Proprietary Markets first reported a position in Edwards Lifesciences in Q4 2014 and held it in 1 quarter.
  • Equitec Proprietary Markets's Edwards Lifesciences position peaked at $123K in Q4 2014.
  • 575 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2015.

Based on Equitec Proprietary Markets's 13F filing for Q1 2015, filed 7 May 2015.